1. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Issue 10184 (11th May 2019) Authors: Heerspink, Hiddo J L; Parving, Hans-Henrik; Andress, Dennis L; Bakris, George; Correa-Rotter, Ricardo; Hou, Fan-Fan; Kitzman, Dalane W; Kohan, Donald; Makino, Hirofumi; McMurray, John J V; Melnick, Joel Z; Miller, Michael G; Pergola, Pablo E; Perkovic, Vlado; Tobe, Sheldon; Yi, Tingting; Wigderso... Journal: Lancet Issue: Volume 393:Issue 10184(2019) Page Start: 1937 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Baseline characteristics and enrichment results from the SONAR trial. Issue 8 (1st May 2018) Authors: Heerspink, Hiddo J.L.; Andress, Dennis L.; Bakris, George; Brennan, John J.; Correa‐Rotter, Ricardo; Hou, Fan Fan; Kitzman, Dalane W.; Kohan, Donald; Makino, Hirofumi; McMurray, John; Perkovic, Vlado; Tobe, Sheldon; Wigderson, Melissa; Yi, Tingting; Parving, Hans‐Henrik; de Zeeuw, Dick Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 8(2018) Page Start: 1829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of Angiotensin Type 1A Receptors in Principal Cells of the Collecting Duct on Blood Pressure and Hypertension. Issue 6 (June 2016) Authors: Chen, Daian; Stegbauer, Johannes; Sparks, Matthew A.; Kohan, Donald; Griffiths, Robert; Herrera, Marcela; Gurley, Susan B.; Coffman, Thomas M. Journal: Hypertension Issue: Volume 67:Issue 6(2016:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial. Issue 2 (26th November 2020) Authors: Koomen, Jeroen V.; Stevens, Jasper; Bakris, George; Correa‐Rotter, Ricardo; Hou, Fan Fan; Kitzman, Dalane W.; Kohan, Donald; Makino, Hirofumi; McMurray, John J. V.; Parving, Hans‐Henrik; Perkovic, Vlado; Tobe, Sheldon W.; de Zeeuw, Dick; Heerspink, Hiddo J. L. Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 2(2021) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MO230A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY (THE ALIGN STUDY). (29th May 2021) Authors: Lambers Heerspink, Hiddo; Kohan, Donald; Lafayette, Richard; Levin, Adeera; Zhang, Hong; Glicklich, Aland; Camargo, Marianne; King, Andrew; Barratt, Jonathan Journal: Nephrology dialysis transplantation Issue: Volume 36(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OS 06-04 CHANGES IN GENE EXPRESSION PATHWAYS PREDICT DELAYED SODIUM EXCRETION DURING SALINE INFUSION. (September 2016) Authors: Hunt, Steven; Hopkins, Paul; Nanjee, Nazeem; Schwander, Karen; Kohan, Donald; Rao, D. C.; Williams, Gordon Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers. (29th August 2020) Authors: Schievink, Bauke; de Zeeuw, Dick; Smink, Paul A; Andress, Dennis; Brennan, John J; Coll, Blai; Correa-Rotter, Ricardo; Hou, Fan Fan; Kohan, Donald; Kitzman, Dalane W; Makino, Hirofumi; Parving, Hans-Henrik; Perkovic, Vlado; Remuzzi, Giuseppe; Tobe, Sheldon; Toto, Robert; Hoekman, Jarno; Lambers H... Journal: European journal of preventive cardiology Issue: Volume 23:Number 7(2016) Page Start: 758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers. (May 2016) Authors: Schievink, Bauke; de Zeeuw, Dick; Smink, Paul A; Andress, Dennis; Brennan, John J; Coll, Blai; Correa-Rotter, Ricardo; Hou, Fan Fan; Kohan, Donald; Kitzman, Dalane W; Makino, Hirofumi; Parving, Hans-Henrik; Perkovic, Vlado; Remuzzi, Giuseppe; Tobe, Sheldon; Toto, Robert; Hoekman, Jarno; Lambers H... Journal: European journal of preventive cardiology Issue: Volume 23:Number 7(2016) Page Start: 758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy. Issue 6 (9th March 2018) Authors: Heerspink, Hiddo J. L.; Andress, Dennis L.; Bakris, George; Brennan, John J.; Correa‐Rotter, Ricardo; Dey, Jyotirmoy; Hou, Fan Fan; Kitzman, Dalane W.; Kohan, Donald; Makino, Hirofumi; McMurray, John; Perkovic, Vlado; Tobe, Sheldon; Wigderson, Melissa; Parving, Hans‐Henrik; de Zeeuw, Dick Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 6(2018) Page Start: 1369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Thromboxane Prostanoid Receptors Enhance Contractions, Endothelin-1, and Oxidative Stress in Microvessels From Mice With Chronic Kidney Disease. Issue 5 (May 2015) Authors: Wang, Cheng; Luo, Zaiming; Kohan, Donald; Wellstein, Anton; Jose, Pedro A.; Welch, William J.; Wilcox, Christopher S.; Wang, Dan Journal: Hypertension Issue: Volume 65:Issue 5(2015:May) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗